Treatment of substance use disorders with co-occurring severe mental health disorders
- PMID: 31157674
- DOI: 10.1097/YCO.0000000000000510
Treatment of substance use disorders with co-occurring severe mental health disorders
Abstract
Purpose of review: To provide an update of treatment for substance use in patients with co-occurring substance use disorders (SUD) and mental health disorders (dual diagnosis) with a focus on both pharmacological and psychosocial interventions.
Recent findings: A total of 1435 abstracts were identified, of which we selectively reviewed 43 for this narrative review. There is emerging evidence, both clinical and neurobiological, that clozapine is a more efficacious antipsychotic in treatment of individuals with schizophrenia and SUD. The use of depot atypical antipsychotic paliperidone palmitate in this population is also promising. Although valproate remains the treatment of choice in individuals with bipolar disorder and SUD, present evidence suggests that lithium and quetiapine may not be effective in this population. Naltrexone is the most effective anticraving agent in individuals with severe mental illness (SMI) and comorbid alcohol use disorders. The use of opioid substitution therapy in individuals with SMI and comorbid opioid use disorders is also associated with favorable outcomes. Varenicline shows promise in patients with SMI who smoke tobacco. Psychosocial interventions should be instituted early in the course of treatment. They should ideally be high intensity and based on established therapies used for SUD.
Summary: The paucity of systematic studies in individuals with co-occurring mental health disorders and SUD remains a concern, given the enormous burden that they pose. However, there are a number of studies which have evaluated interventions, both psychosocial and pharmacological, which show promise and can guide clinical practice. VIDEO ABSTRACT: http://links.lww.com/YCO/A49.
Similar articles
-
Treatment of dual diagnosis disorders.Curr Opin Psychiatry. 2012 May;25(3):194-200. doi: 10.1097/YCO.0b013e328351a3e0. Curr Opin Psychiatry. 2012. PMID: 22395768 Review.
-
Management of comorbid bipolar disorder and substance use disorders.Am J Drug Alcohol Abuse. 2017 Jul;43(4):366-376. doi: 10.1080/00952990.2017.1292279. Epub 2017 Mar 16. Am J Drug Alcohol Abuse. 2017. PMID: 28301219 Review.
-
Management of schizophrenia with substance use disorders.Psychiatr Clin North Am. 2009 Dec;32(4):821-33. doi: 10.1016/j.psc.2009.09.002. Psychiatr Clin North Am. 2009. PMID: 19944886 Review.
-
Management of comorbid bipolar disorder and substance abuse.J Clin Psychiatry. 2006;67 Suppl 7:24-30. J Clin Psychiatry. 2006. PMID: 16961421 Review.
-
Treatment of substance use disorders in schizophrenia.Am J Drug Alcohol Abuse. 2017 Jul;43(4):377-390. doi: 10.1080/00952990.2016.1200592. Epub 2016 Aug 9. Am J Drug Alcohol Abuse. 2017. PMID: 27715317 Review.
Cited by
-
Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations.Front Psychiatry. 2024 Sep 20;15:1451832. doi: 10.3389/fpsyt.2024.1451832. eCollection 2024. Front Psychiatry. 2024. PMID: 39371908 Free PMC article. Review.
-
Research landscape analysis on dual diagnosis of substance use and mental health disorders: key contributors, research hotspots, and emerging research topics.Ann Gen Psychiatry. 2024 Aug 30;23(1):32. doi: 10.1186/s12991-024-00517-x. Ann Gen Psychiatry. 2024. PMID: 39215276 Free PMC article.
-
TAPS-tool reveals severe under detection of substance use problems in patients with severe mental illness.PLoS One. 2024 Jul 24;19(7):e0305142. doi: 10.1371/journal.pone.0305142. eCollection 2024. PLoS One. 2024. PMID: 39047031 Free PMC article.
-
Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development.INNOSC Theranostics Pharmacol Sci. 2024 Apr 30;7(2):1472. doi: 10.36922/itps.1472. INNOSC Theranostics Pharmacol Sci. 2024. PMID: 38766548 Free PMC article.
-
Substance use and its association with mental health among Swiss medical students: A cross-sectional study.Int J Soc Psychiatry. 2024 Jun;70(4):808-817. doi: 10.1177/00207640241232321. Epub 2024 Feb 29. Int J Soc Psychiatry. 2024. PMID: 38420921 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials